Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

被引：0
|
作者：
Greg W Mattingly
Richard H Weisler
Joel Young
Ben Adeyi
Bryan Dirks
Thomas Babcock
Robert Lasser
Brian Scheckner
David W Goodman
机构：
[1] St Charles Psychiatric Associates/Midwest Research,Duke University Medical Center
[2] 4801 Weldon Spring Pkwy,undefined
[3] Durham,undefined
[4] NC,undefined
[5] and University of North Carolina at Chapel Hill,undefined
[6] Rochester Center for Behavioral Medicine,undefined
[7] Shire Development LLC,undefined
[8] Formerly of Shire Development LLC,undefined
[9] Johns Hopkins University School of Medicine,undefined
来源：
BMC Psychiatry | / 13卷
关键词：
Lisdexamfetamine dimesylate (LDX); Attention-deficit/hyperactivity disorder (ADHD); Adults; Response; Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK
    Zimovetz, Evelina A.
    Joseph, Alain
    Ayyagari, Rajeev
    Mauskopf, Josephine A.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (01): : 21 - 35
  • [32] Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder
    Gordon, Chanelle T.
    Fabiano, Gregory A.
    Hulme, Kevin F.
    Sodano, Sandro M.
    Adragna, Michael
    Lim, Rachel
    Stanford, Samantha
    Janikowski, Leah
    Bufalo, Bradley
    Rodriguez, Zulema
    Swiatek, Denise
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2021, 29 (04) : 308 - 318
  • [33] A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK
    Evelina A. Zimovetz
    Alain Joseph
    Rajeev Ayyagari
    Josephine A. Mauskopf
    The European Journal of Health Economics, 2018, 19 : 21 - 35
  • [34] Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
    Joseph, Alain
    Cloutier, Martin
    Guerin, Annie
    Nitulescu, Roy
    Sikirica, Vanja
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 391 - 405
  • [35] LONG-TERM SAFETY AND EFFICACY OF LISDEXAMFETAMINE DIMESYLATE BY AGE SUBGROUP IN CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
    Coghill, D.
    Hernandez Otero, I.
    Nagy, P.
    Soutullo, C. A.
    Zuddas, A.
    Geibel, B.
    Naser, N.
    Yan, B.
    Banaschewski, T.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 : 162 - 162
  • [36] A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorder
    Hammerness, Paul
    Zusman, Randall
    Systrom, David
    Surman, Craig
    Baggish, Aaron
    Schillinger, Mary
    Shelley-Abrahamson, Rachel
    Wilens, Timothy E.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2013, 14 (04): : 299 - 306
  • [37] EFFECT OF LISDEXAMFETAMINE DIMESYLATE ON FUNCTIONAL IMPAIRMENT IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    Soutullo, C. A.
    Banaschewski, T.
    Lecendreux, M. L.
    Bloomfield, R.
    Hodgkins, P.
    Coghill, D. R.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [38] The first European studies of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Coghill, David
    Banaschewski, Tobias
    Lecendreux, Michel
    Soutullo, Cesar
    Johnson, Mats
    Zuddas, Alessandro
    Anderson, Colleen
    Civil, Richard
    Dauphin, Matthew
    Higgins, Nicholas
    Lyne, Andrew
    Gasior, Maria
    Squires, Liza
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S125 - S125
  • [39] The first European studies of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Coghill, D. R.
    Banaschewski, T.
    Lecendreux, M.
    Soutullo, C.
    Johnson, M.
    Zuddas, A.
    Anderson, C.
    Civil, R.
    Dauphin, M.
    Lyne, A.
    Gasior, M.
    Squires, L. A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [40] EFFECT OF TREATMENT WITH LISDEXAMFETAMINE DIMESYLATE ON SELF-REPORTED QUALITY OF LIFE IN ADULTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    Giblin, J.
    Brams, M.
    Gao, J.
    Gasior, M.
    Squires, L.
    Wigal, T.
    EUROPEAN PSYCHIATRY, 2010, 25
12345